Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.

Donald Trump paid tribute to Charlie Kirk after the conservative activist was fatally shot at a speaking event at Utah Valley ...